Sign in
Explore the registryTrack Amlitelimab's trials

A Phase 2a/b Study of the Efficacy and Safety of Subcutaneous Amlitelimab in Adults With Nonresponsive Celiac Disease

AmlitelimabOngoingActive not recruitingPhase 2Open NCT06557772 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…